View Section: Financials
Acotec Scientific Statements
66
Acotec Scientific Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-06-30
%
175.32
100
30.552
17.4
144.77
82.6
77.07
44
58.421
33.3
134.82
76.9
9.951
5.7
21.684
12.4
-0.341
-0.2
31.29
17.8
0.194
0.1
31.096
17.7
0.103
301.1
2021-12-31
%
303.81
100
37.874
12.5
265.94
87.5
141.29
46.5
116.08
38.2
284.13
93.5
-18.192
-6
-7.827
-2.6
—
0
-67.243
-22.1
11.834
3.9
-79.077
-26.03
-0.319
248.07
2021-06-30
%
86.875
100
9.879
11.4
76.996
88.6
24.152
27.8
17.882
20.6
40.735
46.9
36.261
41.7
0.837
1
—
0
31.504
36.3
4.024
4.6
27.48
31.6
0.088
313.39
2021-03-31
%
53.32
100
6.639
12.5
46.681
87.5
35.102
65.8
35.138
65.9
72.747
136.4
-26.066
-48.9
-1.235
-2.3
—
0
-38.094
-71.4
1.922
3.6
-40.016
-75.05
-0.128
313.39
View Section: Balance Sheet